Also trades as: DRMAW (NASDAQ) · $vol 0M
DRMA NASDAQ
Dermata Therapeutics, Inc.
1W: -2.6%
1M: -13.3%
3M: -17.2%
YTD: -49.1%
1Y: -78.4%
3Y: -93.2%
5Y: -99.9%
$1.10
-0.01 (-0.45%)
Weekly Expected Move ±4.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.4M
52W Range0.9509-5.87
Volume17,622
Avg Volume73,512
Beta0.69
Dividend—
Analyst Ratings
Company Info
CEOGerald T. Proehl
Employees9
SectorHealthcare
IndustryBiotechnology
IPO Date2021-08-13
Websitedermatarx.com
3525 Del Mar Heights Road
San Diego, CA 92130
US
San Diego, CA 92130
US
858 800 2543
About Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Latest News
$DRMA Technical Breakout, Low Float, Fundemental Shift with aproaching revenue generating Product Release
12 Health Care Stocks Moving In Tuesday's After-Market Session
Dermata Therapeutics GAAP EPS of -$8.16
12 Health Care Stocks Moving In Friday's Intraday Session
Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| PROEHL GERALD T | A-Award | 170,068 | — | 2026-08-16 |
| PROEHL GERALD T | A-Award | 1,360,544 | $1.47 | 2026-08-16 |
| PROEHL GERALD T | A-Award | 1,360,544 | $1.47 | 2026-08-16 |
| PROEHL GERALD T | A-Award | 170,068 | $1.47 | 2026-08-16 |
| PROEHL GERALD T | A-Award | 170,068 | $1.47 | 2026-08-16 |